跳至主要内容
临床试验/ACTRN12616000903482
ACTRN12616000903482尚未招募3 期

The Obstructive Sleep apnoea Intervention in AF (OSI-AF) randomised trial: Obstructive sleep apnoea treatment to reduce atrial fibrillation burden and morbidity

niversity of Sydney0 个研究点目标入组 200 人开始时间: 2016年7月7日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 1) Males and females with a history of paroxysmal (at least 2 prior attacks) or persistent AF (<12 months duration [in sinus rhythm at study entry]);
  • 2) Age 18-75;
  • 3) Polysomnography diagnosed OSA of at least moderate severity (AHI >=15);
  • 4) Ability to provide informed consent.

排除标准

  • 1) Severe OSA related hypoxemia (>10% sleep time with oxygen saturation <80%) and/or awake oxygen saturation less than 92%%
  • 2) Severe respiratory disease (eg Chronic Obstructive Pulmonary Disease or (COPD)
  • 3) Current or prior mechanical treatment for OSA with CPAP or MAS
  • 4) >50% of apnoeas and/or hyponeas associated with Cheyne-Stokes Respiration (CSR) or Central Sleep Apnoea (CSA)
  • 5) Increased risk of sleep-related accident and / or excessive sleepiness defined by any of:
  • * Severe sleepiness as defined by Epworth Sleepiness Scale (>15)
  • *Driver occupation (eg taxi, courier or truck driver)
  • *Sleepiness-related motor vehicle accident, or near accident, within last 12 months prior to enrolment
  • 6) Any relative or absolute contra-indication to CPAP or MAS therapy including chronic cranial injury; recurrent pneumothorax; indication for oral-pharyngeal surgery, edentulous, or loose teeth
  • 7) Any severe other cardiac disease likely to impact ability to comply:

研究者

相似试验

Efficacy of sleep apnoea (OSA) therapy for the... | 临床试验